Real-time enrollment status for this multiple myeloma refractory clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:33 PM UTC
| NCT Number | NCT07802717 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma Refractory |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vyriad, Inc. |
| Last Updated on CT.gov | September 21, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT07802717 is currently recruiting participants. This phase1 study for multiple myeloma refractory is actively seeking new participants at 1 location across the United States. The study is sponsored by Vyriad, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07802717 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07802717 was last updated 3 weeks ago (September 21, 2026). HelloStudys verifies this status automatically.